Kestra Private Wealth Services’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.78M | Sell |
25,855
-33,676
| -57% | -$2.32M | 0.03% | 530 |
|
|
2025
Q1 | $4.13M | Buy |
59,531
+10,891
| +22% | +$756K | 0.07% | 287 |
|
|
2024
Q4 | $4.18M | Buy |
48,640
+13,331
| +38% | +$1.15M | 0.07% | 275 |
|
|
2024
Q3 | $4.2M | Sell |
35,309
-4,832
| -12% | -$575K | 0.08% | 263 |
|
|
2024
Q2 | $5.73M | Sell |
40,141
-1,111
| -3% | -$159K | 0.11% | 199 |
|
|
2024
Q1 | $5.3M | Buy |
41,252
+2,419
| +6% | +$311K | 0.12% | 192 |
|
|
2023
Q4 | $4.02M | Buy |
38,833
+16,625
| +75% | +$1.72M | 0.1% | 218 |
|
|
2023
Q3 | $2.02M | Buy |
22,208
+6,340
| +40% | +$577K | 0.06% | 307 |
|
|
2023
Q2 | $1.28M | Sell |
15,868
-1,020
| -6% | -$82.5K | 0.04% | 385 |
|
|
2023
Q1 | $1.34M | Sell |
16,888
-338
| -2% | -$26.9K | 0.05% | 345 |
|
|
2022
Q4 | $1.17M | Sell |
17,226
-4,598
| -21% | -$311K | 0.06% | 336 |
|
|
2022
Q3 | $1.09M | Sell |
21,824
-810
| -4% | -$40.3K | 0.06% | 319 |
|
|
2022
Q2 | $1.26M | Buy |
22,634
+2,876
| +15% | +$160K | 0.07% | 297 |
|
|
2022
Q1 | $1.1M | Buy |
19,758
+776
| +4% | +$43.1K | 0.05% | 354 |
|
|
2021
Q4 | $1.06M | Sell |
18,982
-100
| -0.5% | -$5.6K | 0.05% | 369 |
|
|
2021
Q3 | $916K | Sell |
19,082
-378
| -2% | -$18.1K | 0.05% | 376 |
|
|
2021
Q2 | $815K | Buy |
19,460
+7,372
| +61% | +$309K | 0.05% | 387 |
|
|
2021
Q1 | $407K | Sell |
12,088
-806
| -6% | -$27.1K | 0.03% | 509 |
|
|
2020
Q4 | $453K | Buy |
12,894
+6,506
| +102% | +$229K | 0.03% | 458 |
|
|
2020
Q3 | $222K | Buy |
+6,388
| New | +$222K | 0.02% | 572 |
|